Key Takeaways
- • MiRus secures $1.5 billion corporate round led by Boston Scientific, the week's largest deal, positioning the Marietta, Georgia-based orthopedic and spinal implant company to advance next-generation musculoskeletal technologies; Boston Scientific acquires 34% equity stake as strategic investor.
- • Hark raises $700 million Series A, a landmark funding for AI hardware startups, backed by a blue-chip investor consortium including Nvidia, Intel Capital, AMD, Qualcomm Ventures, ARK Investment Management, and Salesforce Ventures, signaling institutional conviction in personalized AI devices.
- • Physical tech and AI dominate the week's funding landscape, with medical devices, futuristic AI gadgets, and specialized frontier labs capturing outsized capital allocation, reflecting investor appetite for both healthcare innovation and advanced computing hardware.
- • MiRus has raised $1.6 billion to date, establishing itself as a well-capitalized player in the orthopedic sector; Hark, at only 1 year old, achieved a mega-round valuation with plans to launch products by summer 2026.
- • Multi-sector diversification evident across top deals, including aerospace, defense, fintech, and retail technology, though medical devices and AI collectively represent the dominant share of announced capital.
Summary
This week's largest U.S. startup funding rounds reflect a resurgence in physical technology and purpose-built hardware, bucking recent narratives of pure software and AI dominance. The $1.5 billion corporate round for MiRus, led by Boston Scientific, topped the rankings as the week's flagship deal. MiRus, based in Marietta, Georgia, develops implants and treatment systems targeting musculoskeletal and spinal disorders. Boston Scientific's strategic investment includes a 34% equity stake, underscoring the acquirer's commitment to next-generation orthopedic technologies. The company has accumulated $1.6 billion in total funding to date, positioning it as a well-capitalized competitor in the specialized medical device sector.
The second-largest deal was a $700 million Series A for Hark, an artificial intelligence startup focused on personalized AI devices and next-generation hardware. Founded just one year prior, Hark attracted a prestigious consortium of investors led by Parkway Venture Capital, with participation from semiconductor heavyweights Nvidia, Intel Capital, AMD, and Qualcomm Ventures. The round also included prominent venture and growth investors such as ARK Investment Management, Prime Movers Lab, Salesforce Ventures, and Align Ventures. The breadth of the investor base—spanning chipmakers, asset managers, and specialized venture firms—signals confidence in the commercialization of consumer and enterprise AI hardware. Hark announced plans to release a product by summer 2026, establishing a near-term catalyst for market validation.
Beyond the top two deals, the week's funding landscape encompassed aerospace and defense, fintech, and retail technology sectors. This diversification suggests that while AI remains a significant draw for capital, investors are increasingly deploying dry powder across hardware, medical technology, and specialized infrastructure plays. The week's funding roundup underscores a strategic pivot: after years of software-centric valuations, hardware-enabled solutions—particularly in healthcare and personalized computing—are commanding substantial institutional backing.
The second-largest deal was a $700 million Series A for Hark, an artificial intelligence startup focused on personalized AI devices and next-generation hardware. Founded just one year prior, Hark attracted a prestigious consortium of investors led by Parkway Venture Capital, with participation from semiconductor heavyweights Nvidia, Intel Capital, AMD, and Qualcomm Ventures. The round also included prominent venture and growth investors such as ARK Investment Management, Prime Movers Lab, Salesforce Ventures, and Align Ventures. The breadth of the investor base—spanning chipmakers, asset managers, and specialized venture firms—signals confidence in the commercialization of consumer and enterprise AI hardware. Hark announced plans to release a product by summer 2026, establishing a near-term catalyst for market validation.
Beyond the top two deals, the week's funding landscape encompassed aerospace and defense, fintech, and retail technology sectors. This diversification suggests that while AI remains a significant draw for capital, investors are increasingly deploying dry powder across hardware, medical technology, and specialized infrastructure plays. The week's funding roundup underscores a strategic pivot: after years of software-centric valuations, hardware-enabled solutions—particularly in healthcare and personalized computing—are commanding substantial institutional backing.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.